Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TLDR
In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.Abstract:
Colorectal cancer (CRC) is a common cancer worldwide with complex etiology. Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with CRC in the past decade. A series of gut microbiota studies show that CRC patients carry a high abundance of F. nucleatum in the tumor tissue and fecal, and etiological studies have clarified the role of F. nucleatum as a pro-carcinogenic bacterium in various stages of CRC. In this review, we summarize the biological characteristics of F. nucleatum and the epidemiological associations between F. nucleatum and CRC, and then highlight the mechanisms by which F. nucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment (TME). We also discuss the research gap in this field and give our perspective for future studies. These findings will pave the way for manipulating gut F. nucleatum to deal with CRC in the future.read more
Citations
More filters
Journal ArticleDOI
Oral microbiota in human systematic diseases
TL;DR: In this article , the authors discussed emerging and exciting evidence of complex and important connections between the oral microbes and multiple human systemic diseases, and the possible contribution of the oral microorganisms to systemic diseases.
Journal ArticleDOI
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Cheng Kong,Lei Liang,Guang Liu,Lutao Du,Yongzhi Yang,Jianqiang Liu,Debing Shi,Xinxiang Li,Yan-yan Ma +8 more
TL;DR: The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls, suggesting that altered microbiome–metabolome interplay helps explain the pathogenesis of EO.CRC.
Journal ArticleDOI
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
TL;DR: Gut microbiota and their metabolites influence the progression and causation of CRC, and the association analysis of metabolomics and gut microbiome will provide novel strategies for the prevention, diagnosis, and therapy of CRC.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
References
More filters
Journal ArticleDOI
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
TL;DR: Evidence for the influence of the microbiome, diet, and environmental factors on CRC incidence and outcomes is reviewed and features of the intestinal microbiome might be used for CRC screening and modified for chemoprevention and treatment are modified.
Journal ArticleDOI
A history of exploring cancer in context.
Shelly Maman,Isaac P. Witz +1 more
TL;DR: How much progress has been made in understanding how the tumour microenvironment influences tumour progression since its initial description is described, highlighting the controversies in the field and the potential of targeting components of the microenvironment for cancer therapy.
Journal ArticleDOI
Physical traits of cancer.
TL;DR: The authors provide a conceptual framework and discuss the origins of these distinct physical traits of cancer and how they enable and synergize with aberrant cancer biology to fuel cancer initiation, progression, immune evasion, and treatment resistance.
Journal ArticleDOI
Emerging cytokine networks in colorectal cancer
TL;DR: How cancer mutations and epigenetic adaptations influence the oncogenic potential of cytokines is discussed, a relatively unexplored area that could yield crucial insights into tumour immunology and facilitate the effective application of cytokine-modulatory therapies for CRC.
Journal ArticleDOI
Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
Brandilyn A. Peters,Jing Wu,Zhiheng Pei,Zhiheng Pei,Liying Yang,Mark P. Purdue,Neal D. Freedman,Eric J. Jacobs,Susan M. Gapstur,Richard B. Hayes,Jiyoung Ahn +10 more
TL;DR: The relationship of oral microbiota with EAC and ESCC risk in a prospective study nested in two cohorts was examined and the periodontal pathogen Tannerella forsythia and the species Streptococcus pneumoniae were found to be associated with higher risk of EAC.